STUDIO
Follow Us

Terms of Use Privacy Policy

Here’s Why AstraZeneca Is Worth $98.7B to Pfizer

April 28 (Bloomberg) -- Bloomberg’s Olivia Sterns examines Pfizer’s renewed bid for AstraZeneca in what would be a $98.7 billion deal on Bloomberg Television’s “In The Loop.”

Source: Bloomberg

Top Trending Videos